|
ES2193133T3
(es)
*
|
1991-07-13 |
2003-11-01 |
Dade Behring Marburg Gmbh |
Uso de peptidos derivados de los genes e6 y e7 de hpv-16 para fines.
|
|
GB9207701D0
(en)
*
|
1992-04-08 |
1992-05-27 |
Cancer Res Campaign Tech |
Papillomavirus e7 protein
|
|
IL105554A
(en)
*
|
1992-05-05 |
1999-08-17 |
Univ Leiden |
Peptides of human papillomavirus for use in preparations elicit a human T cell response
|
|
GB9306731D0
(en)
*
|
1993-03-31 |
1993-05-26 |
Cancer Res Campaign Tech |
Vaccines
|
|
US6013517A
(en)
|
1994-05-09 |
2000-01-11 |
Chiron Corporation |
Crossless retroviral vectors
|
|
AU2585395A
(en)
|
1994-05-09 |
1995-11-29 |
Chiron Corporation |
Retroviral vectors having a reduced recombination rate
|
|
AUPN015794A0
(en)
*
|
1994-12-20 |
1995-01-19 |
Csl Limited |
Variants of human papilloma virus antigens
|
|
WO1996026277A1
(en)
*
|
1995-02-24 |
1996-08-29 |
Cantab Pharmaceuticals Research Limited |
Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
|
|
AUPN443995A0
(en)
*
|
1995-07-27 |
1995-08-17 |
Csl Limited |
Papillomavirus polyprotein
|
|
CZ28899A3
(cs)
*
|
1996-07-29 |
1999-07-14 |
Cantab Pharmaceuticals Research Limited |
Polypeptidy použitelné jako imunoterapeutická činidla a způsoby přípravy polypeptidů
|
|
GB9717953D0
(en)
|
1997-08-22 |
1997-10-29 |
Smithkline Beecham Biolog |
Vaccine
|
|
DE19925199A1
(de)
*
|
1999-06-01 |
2000-12-07 |
Medigene Ag |
Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
|
|
DE19925235A1
(de)
|
1999-06-01 |
2000-12-07 |
Medigene Ag |
Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
|
|
AU2007201619B2
(en)
*
|
1999-09-16 |
2011-05-12 |
Eisai Inc. |
Nucleic acids encoding polyepitope polypeptides
|
|
CA2384987A1
(en)
*
|
1999-09-16 |
2001-03-22 |
Zycos Inc. |
Nucleic acids encoding polyepitope polypeptides
|
|
US8128922B2
(en)
|
1999-10-20 |
2012-03-06 |
Johns Hopkins University |
Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
|
|
JP5087201B2
(ja)
|
2000-08-03 |
2012-12-05 |
ジョンズ・ホプキンス・ユニバーシティ |
抗原に小胞体シャペロンポリペプチドを連結した分子ワクチン
|
|
CN1694958A
(zh)
*
|
2002-09-13 |
2005-11-09 |
昆士兰大学 |
以密码子翻译效率为基础的基因表达系统
|
|
US9701725B2
(en)
|
2003-05-05 |
2017-07-11 |
The Johns Hopkins University |
Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
|
|
WO2006073970A2
(en)
|
2005-01-06 |
2006-07-13 |
The Johns Hopkins University |
Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
|
|
JP2008528004A
(ja)
*
|
2005-01-26 |
2008-07-31 |
ザ ジョンズ ホプキンス ユニバーシティー |
突然変異癌タンパク質抗原およびカルレティキュリンをコードするプラスミドを用いる抗癌dnaワクチン
|
|
US9085638B2
(en)
|
2007-03-07 |
2015-07-21 |
The Johns Hopkins University |
DNA vaccine enhancement with MHC class II activators
|
|
US8466259B2
(en)
|
2007-12-07 |
2013-06-18 |
National Health Research Institutes |
Adjuvants
|
|
TWI376385B
(en)
|
2007-12-07 |
2012-11-11 |
Nat Health Research Institutes |
Production of lipidated proteins in e. coli
|
|
US8287880B2
(en)
|
2009-06-02 |
2012-10-16 |
National Health Research Institutes |
Lipidated vaccine against dengue virus infection
|
|
TWI409275B
(zh)
|
2009-06-22 |
2013-09-21 |
Nat Health Research Institutes |
脂質化腫瘤相關抗原及其免疫治療的組成物及方法
|
|
TW201221642A
(en)
|
2010-11-15 |
2012-06-01 |
Nat Health Research Institutes |
Method of producing lipidated polypeptides
|
|
TWI507413B
(zh)
|
2010-11-15 |
2015-11-11 |
Nat Health Research Institutes |
脂質化多抗原表位疫苗
|
|
KR20240093830A
(ko)
*
|
2011-10-12 |
2024-06-24 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
인간 파필로마 바이러스에 대한 백신 및 이것을 사용하는 방법
|
|
JP6517779B2
(ja)
|
2013-03-12 |
2019-05-22 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
ヒトパピローマウイルスの改良型ワクチンおよびその使用方法
|
|
KR20170121301A
(ko)
*
|
2015-03-18 |
2017-11-01 |
옴니사이트 |
변형된 알파 바이러스 표면 당 단백질 및 종양-관련 항원을 포함하는 융합 단백질 및 이의 방법
|
|
KR102877389B1
(ko)
*
|
2017-06-28 |
2025-10-28 |
리제너론 파아마슈티컬스, 인크. |
항-인간 유두종 바이러스 (hpv) 항원-결합 단백질 및 그의 사용 방법
|